Randomized Phase 2 Study of Guadecitabine in Patients with HMA-Naive Higher Risk Myelodysplastic Syndromes (MDS) or Chronic Myelomonocytic Leukemia (CMML)
Savona, M.R, Garcia-Manero, G, Roboz, G.J, Walsh, K.J, Kropf, P.L, Issa, J.P, O’Connell, C.L, Tibes, R, Yee, K.W.L, Stock, W, Lunin, S, Berdeja, J.G, Naim, S, Hao, Y, Azab, M, Kantarjian, H
Published in Leukemia research (01.04.2017)
Published in Leukemia research (01.04.2017)
Get full text
Journal Article
Improved Survival from Transfusion Dependence in Lower-Risk MDS Receiving Iron Chelation, Adjusting for MDS and Patient Characteristics: An MDS-Can Analysis
Leitch, H.A, Wells, R.A, Chodirker, L, Zhu, N, Nevill, T.J, Yee, K.W.L, Leber, B, Keating, M.M, Sabloff, M, Hilaire, E. St, Kumar, R, Delage, R, Geddes, M, Storring, J.M, Shamy, A, Elemary, M, Lenis, M, Francis, J, Zhang, L, Buckstein, R
Published in Leukemia research (01.04.2017)
Published in Leukemia research (01.04.2017)
Get full text
Journal Article
283 - Improved Survival from Transfusion Dependence in Lower-Risk MDS Receiving Iron Chelation, Adjusting for MDS and Patient Characteristics: An MDS-Can Analysis
Leitch, H.A., Wells, R.A., Chodirker, L., Zhu, N., Nevill, T.J., Yee, K.W.L., Leber, B., Keating, M.M., Sabloff, M., Hilaire, E. St, Kumar, R., Delage, R., Geddes, M., Storring, J.M., Shamy, A., Elemary, M., Lenis, M., Francis, J., Zhang, L., Buckstein, R.
Published in Leukemia research (01.04.2017)
Published in Leukemia research (01.04.2017)
Get full text
Journal Article
60 - Randomized Phase 2 Study of Guadecitabine in Patients with HMA-Naive Higher Risk Myelodysplastic Syndromes (MDS) or Chronic Myelomonocytic Leukemia (CMML)
Savona, M.R., Garcia-Manero, G., Roboz, G.J., Walsh, K.J., Kropf, P.L., Issa, J.P., O’Connell, C.L., Tibes, R., Yee, K.W.L., Stock, W., Lunin, S., Berdeja, J.G., Naim, S., Hao, Y., Azab, M., Kantarjian, H.
Published in Leukemia research (01.04.2017)
Published in Leukemia research (01.04.2017)
Get full text
Journal Article
Venous thromboembolism prevention during asparaginase-based therapy for acute lymphoblastic leukemia
Sibai, H, Seki, J T, Wang, T Q, Sakurai, N, Atenafu, E G, Yee, K W L, Schuh, A C, Gupta, V, Minden, M D, Schimmer, A D, Brandwein, J M
Published in Current oncology (Toronto) (01.08.2016)
Published in Current oncology (Toronto) (01.08.2016)
Get full text
Journal Article
A phase I II study of imatinib plus reinduction therapy for c-kit-positive relapsed refractory acute myeloid leukemia: inhibition of Akt activation correlates with complete response
BRANDWEIN, J. M, HEDLEY, D. W, CHOW, S, SCHIMMER, A. D, YEE, K. W. L, SCHUH, A. C, GUPTA, V, XU, W, KAMEL-REID, S, MINDEN, M. D
Published in Leukemia (01.06.2011)
Published in Leukemia (01.06.2011)
Get full text
Journal Article
A phase I study of tipifarnib combined with conventional induction and consolidation therapy for previously untreated patients with acute myeloid leukemia aged 60 years and over
BRANDWEIN, J. M, LEBER, B. F, MINDEN, M. D, HOWSON-JAN, K, SCHIMMER, A. D, SCHUH, A. C, GUPTA, V, YEE, K. W. L, WRIGHT, J, MOORE, M, MACALPINE, K
Published in Leukemia (01.04.2009)
Published in Leukemia (01.04.2009)
Get full text
Journal Article